Affinity Investment Advisors LLC bought a new stake in Utah Medical Products, Inc. (NASDAQ:UTMD) in the 1st quarter, HoldingsChannel reports. The firm bought 4,105 shares of the medical instruments supplier’s stock, valued at approximately $362,000.
A number of other large investors also recently modified their holdings of the business. Rehmann Capital Advisory Group purchased a new position in shares of Utah Medical Products during the 4th quarter worth $25,000. BNP Paribas Arbitrage SA grew its holdings in shares of Utah Medical Products by 428.7% during the 1st quarter. BNP Paribas Arbitrage SA now owns 719 shares of the medical instruments supplier’s stock worth $63,000 after purchasing an additional 583 shares during the period. Oppenheimer Asset Management Inc. purchased a new position in shares of Utah Medical Products during the 4th quarter worth $116,000. Metropolitan Life Insurance Co. NY grew its holdings in shares of Utah Medical Products by 605.0% during the 4th quarter. Metropolitan Life Insurance Co. NY now owns 1,537 shares of the medical instruments supplier’s stock worth $128,000 after purchasing an additional 1,319 shares during the period. Finally, Denali Advisors LLC grew its holdings in shares of Utah Medical Products by 8,100.0% during the 1st quarter. Denali Advisors LLC now owns 1,640 shares of the medical instruments supplier’s stock worth $145,000 after purchasing an additional 1,620 shares during the period. Institutional investors own 75.04% of the company’s stock.
In related news, Director Barbara A. Payne sold 1,525 shares of the firm’s stock in a transaction dated Wednesday, February 27th. The stock was sold at an average price of $85.76, for a total transaction of $130,784.00. Following the completion of the transaction, the director now directly owns 21,359 shares in the company, valued at approximately $1,831,747.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 7.30% of the company’s stock.
Shares of Utah Medical Products stock opened at $83.50 on Friday. Utah Medical Products, Inc. has a 12 month low of $73.98 and a 12 month high of $117.65. The stock has a market cap of $310.87 million, a P/E ratio of 22.20 and a beta of 0.68.
Utah Medical Products (NASDAQ:UTMD) last announced its earnings results on Thursday, April 25th. The medical instruments supplier reported $0.84 EPS for the quarter. Utah Medical Products had a return on equity of 16.47% and a net margin of 42.07%. The company had revenue of $10.73 million during the quarter.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 3rd. Investors of record on Friday, June 14th will be issued a dividend of $0.275 per share. This represents a $1.10 dividend on an annualized basis and a yield of 1.32%. The ex-dividend date of this dividend is Thursday, June 13th.
COPYRIGHT VIOLATION WARNING: This news story was first posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The correct version of this news story can be accessed at https://www.baseballdailydigest.com/news/2019/05/18/affinity-investment-advisors-llc-invests-362000-in-utah-medical-products-inc-utmd-stock.html.
Utah Medical Products Profile
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.
See Also: The Structure of a Futures Contract
Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMD).
Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.